Afuco™ Anti-Human LCAT ADCC Therapeutic Antibody, ADCC Enhanced

Anti-LCAT ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-LCAT antibodies are used for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
Supplier Creative Biolabs
Product # AFC-465CL
Pricing Inquiry
Host Human
Target LCAT
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles.
Feedback